Paul E. Zarek

Array ( [id] => 6266660 [patent_doc_number] => 20100298275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Methods of and Formulations for Reducing and Inhibiting the Growth of the Concentration of Microbes in Water-Based Fluids and Systems Used with Them' [patent_app_type] => utility [patent_app_number] => 12/669657 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6167 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298275.pdf [firstpage_image] =>[orig_patent_app_number] => 12669657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10104021 [patent_doc_number] => 09139796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Methods of and formulations for reducing and inhibiting the growth of the concentration of microbes in water-based fluids and systems used with them' [patent_app_type] => utility [patent_app_number] => 12/669667 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5311 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12669667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9944285 [patent_doc_number] => 08993585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-31 [patent_title] => 'Cyclic amine substituted pyrimidinediamines as PKC inhibitors' [patent_app_type] => utility [patent_app_number] => 12/175441 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 146331 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12175441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7811375 [patent_doc_number] => 08133906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Method of treating amblyopia' [patent_app_type] => utility [patent_app_number] => 12/306798 [patent_app_country] => US [patent_app_date] => 2008-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8240 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133906.pdf [firstpage_image] =>[orig_patent_app_number] => 12306798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4456370 [patent_doc_number] => 07893086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Sirtuin modulating compounds' [patent_app_type] => utility [patent_app_number] => 12/214805 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26398 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893086.pdf [firstpage_image] =>[orig_patent_app_number] => 12214805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5350037 [patent_doc_number] => 20090005398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'Methods For The Treatment of Central Nervous System Tumors' [patent_app_type] => utility [patent_app_number] => 12/142845 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18175 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005398.pdf [firstpage_image] =>[orig_patent_app_number] => 12142845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682916 [patent_doc_number] => 20080249142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'HYDROXYBENZOATE SALTS OF METANICOTINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/142471 [patent_app_country] => US [patent_app_date] => 2008-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15562 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249142.pdf [firstpage_image] =>[orig_patent_app_number] => 12142471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6327904 [patent_doc_number] => 20100197712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'USE OF DOPAMINE STABILIZERS' [patent_app_type] => utility [patent_app_number] => 12/452145 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12793 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197712.pdf [firstpage_image] =>[orig_patent_app_number] => 12452145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4950029 [patent_doc_number] => 20080306155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'METHOD FOR TREATING RENAL DISEASE' [patent_app_type] => utility [patent_app_number] => 12/141585 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7954 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306155.pdf [firstpage_image] =>[orig_patent_app_number] => 12141585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4571039 [patent_doc_number] => 07858666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'IRE-1α inhibitors' [patent_app_type] => utility [patent_app_number] => 12/135571 [patent_app_country] => US [patent_app_date] => 2008-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 32668 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858666.pdf [firstpage_image] =>[orig_patent_app_number] => 12135571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568000 [patent_doc_number] => 20100234358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'NERAMEXANE FOR THE TREATMENT OF NYSTAGMUS' [patent_app_type] => utility [patent_app_number] => 12/451950 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10748 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234358.pdf [firstpage_image] =>[orig_patent_app_number] => 12451950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792846 [patent_doc_number] => 20080293820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'METHODS FOR IMPROVING PHYSICAL FUNCTION IN FIBROMYALGIA' [patent_app_type] => utility [patent_app_number] => 12/125302 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9132 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293820.pdf [firstpage_image] =>[orig_patent_app_number] => 12125302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774567 [patent_doc_number] => 08119693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification' [patent_app_type] => utility [patent_app_number] => 12/117570 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 27256 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119693.pdf [firstpage_image] =>[orig_patent_app_number] => 12117570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840497 [patent_doc_number] => 20080280983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'METHODS OF TREATING RETT SYNDROME' [patent_app_type] => utility [patent_app_number] => 12/117586 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8920 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280983.pdf [firstpage_image] =>[orig_patent_app_number] => 12117586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6513661 [patent_doc_number] => 20100216689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'CYTOTOXIC T CELL ACTIVATOR COMPRISING EP4 AGONIST' [patent_app_type] => utility [patent_app_number] => 12/599194 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19990 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216689.pdf [firstpage_image] =>[orig_patent_app_number] => 12599194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760083 [patent_doc_number] => 20080312309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'CONTROLLED RELEASE ORAL FORMULATIONS OF ION CHANNEL MODULATING COMPOUNDS AND RELATED METHODS FOR PREVENTING ARRHYTHMIA' [patent_app_type] => utility [patent_app_number] => 12/114652 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27660 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312309.pdf [firstpage_image] =>[orig_patent_app_number] => 12114652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282971 [patent_doc_number] => 08217069 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes' [patent_app_type] => utility [patent_app_number] => 12/596313 [patent_app_country] => US [patent_app_date] => 2008-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87436 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12596313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887719 [patent_doc_number] => 20080262051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Triazole derivatives which are SMO antagonists' [patent_app_type] => utility [patent_app_number] => 12/082933 [patent_app_country] => US [patent_app_date] => 2008-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12254 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262051.pdf [firstpage_image] =>[orig_patent_app_number] => 12082933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682930 [patent_doc_number] => 20080249156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Combinations of statins and anti-obesity agent and glitazones' [patent_app_type] => utility [patent_app_number] => 12/082039 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8301 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249156.pdf [firstpage_image] =>[orig_patent_app_number] => 12082039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127202 [patent_doc_number] => 08575151 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-11-05 [patent_title] => 'Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance' [patent_app_type] => utility [patent_app_number] => 12/080514 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 15397 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12080514 [rel_patent_id] =>[rel_patent_doc_number] =>)